Germany Cuts Pharma Rebate Level While Keeping Price Freeze
This article was originally published in The Pink Sheet Daily
Executive Summary
German coalition negotiation proposals will see government slash the obligatory rebate for pharma companies while continuing the current prize freeze. But old products will be exempt from HTA.
You may also be interested in...
No Thaw In Sight: German Bill Extends Price Freeze To 2022
Drug price freeze introduced in 2010 would remain to 2022, under draft legislation to revise AMNOG reimbursement system. It introduces some limits on the year of free pricing that companies enjoy after launch.
German Drug Price Freeze Confirmed For Four Years In Latest Reforms
Germany’s pharmaceutical sector reforms represent a mixed bag for industry, with the price freeze set to continue, while rebate levels to health insurers are slashed.
Germany’s Grand Coalition Offers Pharma Little Certainty, Except For Continued Discounts
Germany’s new grand coalition government includes a health minister with no background in health care.